Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Nihon Chouzai Co., Ltd. (3341:JPX), powered by AI.
Nihon Chouzai Co., Ltd. is currently trading at ¥3,910. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Nihon Chouzai Co., Ltd. on Alpha Lenz.
View Nihon Chouzai Co., Ltd.'s valuation metrics on Alpha Lenz.
“Nihon Chouzai Co., Ltd.'s ROE is 2.4%. Explore profitability and growth together.”
Ask for details →Nihon Chouzai Co., Ltd. is a leading pharmaceutical and medical care company based in Japan. It specializes in the operation of a nationwide network of dispensing pharmacies and provides pharmaceutical manufacturing, information, and outsourcing services. The primary function of Nihon Chouzai is to contribute to the health care industry by ensuring the efficient distribution of prescription medications, alongside offering medical consulting and support services. Known for its commitment to innovation, the company leverages technology to streamline pharmacy operations and improve patient care. Nihon Chouzai significantly impacts the healthcare and pharmaceutical sectors by addressing the needs of aging populations and supporting the efficient use of medical resources. The company's role in the market is underscored by its comprehensive service offering, which not only enhances pharmacy operations but also optimizes medical expenditure management, fulfilling a crucial role in advancing Japan's healthcare system.
“Nihon Chouzai Co., Ltd.'s ROE is 2.4%. Explore profitability and growth together.”
Ask for details →Nihon Chouzai Co., Ltd. (ticker: 3341) is a company listed on JPX in the Healthcare sector (Pharmaceutical Retailers). It has approximately 6,063 employees.
The current price is 3,910 with a P/E ratio of -x and P/B of -x.
ROE is 2.37% and operating margin is 1.73%. Annual revenue is $360.5B.